Bước đầu đánh giá kết quả điều trị tắc động mạch phổi cấp ở bệnh nhân cao tuổi

Abstract

The purpose of the study was to evaluate the results and safety of the Vietnam Heart Association's 2022 guideline in the treatment of acute pulmonary embolism in elderly patients. This study described a prospective comparison of results before and after treatment. A total of 50 patients were included in the study, with a mean age of 71.5 ± 6.07 years old where 52% were male. The high risk of death was 14%, while 86% had medium and low risk. Treatment included thrombolysis in 16% of cases and anticoagulation alone in 84%. Clinical symptoms improved after treatment: shortness of breath occurred in 29.7%, tachycardia in 12.8%, and chest pain in 8.2%. The severity index decreased from 12.7 ± 6.7 to 5.2 ± 1.3; pulmonary artery pressure decreased from 45.3 ± 12.7 to 32.7 ± 9.3 mmHg. The hospital mortality rate was 6%, with a cumulative rate of 10% after 1 month. Gastrointestinal bleeding occurred in 2%, and hemorrhage under the skin and hematuria were observed in 4%. The study showed that the overall mortality rate for acute pulmonary embolism in elderly patients after 1 month was 10%, with significant symptom improvement and no severe or critical complication.